Bringing the Oncology Community Together

Login | Register
Home CME OncLive TV Peer Exchange Urology Research iPubs Meetings Blogs Practice Management Partners Publications
December 2012
From the Editor
A Nobel Prize in Waiting: Understanding Unexpected and Prolonged Remissions
Pathways
Wnt Signaling Inhibition: Will Decades of Effort Be Fruitful at Last?
Five Wnt-Related Questions for Heinz-Josef Lenz, MD
Features
PointBreak Trial Misses Goals but Yields Clues for Maintenance Therapy
Profiles in Research
Making Oncology History: Imatinib Pioneer Created His Own Opportunities
Cover Story
Special Populations in Lung Cancer Explored
Feature Article
Going Off-Label: It’s Time to Ponder the Nature of Sufficient Evidence
Clinical Insights
Dual Pathways Must Be Targeted in ER-Positive Breast Cancer
Ponatinib Could Herald “Revolution” in CML Treatment
Study Finds Role for Maintenance Bevacizumab in mCRC
Most Popular Right Now
Four Head and Neck Cancer Highlights From ASCO 2013
Pfizer Discontinues Late-Stage Trial of Inotuzumab Ozogamicin
Study Seeks to Eliminate Clinical Barriers to Bone Marrow Transplants
Resistance Poses Challenges in Chemotherapy Options
SGO Calls for Broad Changes in Managing Patient Care
Publications
External Resources

American Journal of Managed Care
HCPLive
PainLive
Pharmacy Times
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
TargetedHC
OncLive Resources

Archives
Blogs
OncLive TV
Oncology Nurses
Publications
Specialties
Web Exclusives


About Us
Advertise
Advisory Board
Contact Us
Forgot Password
Privacy Policy
Terms & Conditions
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright OncLive 2006-2013
Intellisphere, LLC. All Rights Reserved.